CHARLEBOIS: The drug thats eating the food industry CHARLEBOIS: Ozempic could do what health advocates couldnt -- shrink McDonalds Serena Williams sings praises of GLP-1 drugs for weight loss GLP-1 users abandoning snack foods and alcohol The impact, however, is far from uniform
Abstract Type 2 diabetes mellitus (T2D) affects over 460 million people worldwide and profoundly diminishes their quality of life
CrossRef Adipokines at the crossroad between obesity and cardiovascular disease Filippo Molica, Sandrine Morel, Brenda Kwak, Franoise Rohner-Jeanrenaud, Sabine Steffens Thrombosis and Haemostasis.2015
For a patient already on retinol, SPF, and an established cosmetic dermatology relationship, adding microinfusion at home may produce a smaller incremental benefit than for a patient whose existing routine has more obvious gaps
Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes
Circulating levels decline with age: roughly 200 ng/mL at age 20, dropping to 80 ng/mL by age 60